Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

12.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.3K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Principles of Drug Action01:24

Principles of Drug Action

9.1K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
9.1K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

6.6K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
6.6K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.8K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.9K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

PyMolGen: Database-Driven Molecular Generation of Drug-Like Compounds.

Journal of chemical information and modeling·2026
Same author

Revisiting the knowledge concept of mental health literacy and its relationships with stigma.

Scientific reports·2026
Same author

Rega: A Platform for the Prediction of the Regioselectivity of C-H Functionalization Reactions.

Journal of chemical information and modeling·2026
Same author

Automated Molecular Design in BRADSHAW, Applied to the Optimization of ERAP1 Inhibitors.

Journal of medicinal chemistry·2026
Same author

A Multiomic Liquid Biopsy for the Earlier Detection of Colorectal Cancer.

Cancer prevention research (Philadelphia, Pa.)·2025
Same author

Physics-Based Solubility Prediction for Organic Molecules.

Chemical reviews·2025
Same journal

Correction to "AstraMEV (AI-Guided Structural Assembly of Multi-Epitope Vaccines) Against Infectious Bronchitis Virus".

Journal of chemical information and modeling·2026
Same journal

MolPy: A Large Language Model-Friendly Toolkit for Reactive Topology Editing in Polymer Simulations.

Journal of chemical information and modeling·2026
Same journal

Molecular Mechanisms of KIT Receptor Dimerization and Oncogenic Activation Revealed by Multiscale Simulations.

Journal of chemical information and modeling·2026
Same journal

Structural and Thermodynamic Discrimination between Agonists and Antagonists of Retinoic Acid Receptor γ and the Vitamin D Receptor.

Journal of chemical information and modeling·2026
Same journal

PACEff Builder: An Efficient Platform for Constructing PACE Hybrid-Resolution Models for Molecular Dynamics Simulations of Aqueous Protein, Peptide Assembly, and Membrane Protein Systems.

Journal of chemical information and modeling·2026
Same journal

TransKla: A Local-Global Cross-Attention Based Transformer Approach for Prediction of Lysine Lactylation Sites.

Journal of chemical information and modeling·2026
查看所有相关文章

相关实验视频

Updated: Feb 28, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.6K

查询重要:选择策略如何影响药物发现中的积极学习

Huw J Williams1, Stephen D Pickett2, Andrew Baxter2

  • 1Department of Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow, G11XL, Scotland.

Journal of chemical information and modeling
|February 26, 2026
PubMed
概括
此摘要是机器生成的。

使用SimDMTA模拟设计-制造-测试-分析 (DMTA) 周期,可以加速临床前药物发现. 积极学习中的基于不确定性的抽样与传统方法相比,可以识别出更有效的候选药物.

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.5K

相关实验视频

Last Updated: Feb 28, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.6K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.6K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.5K

科学领域:

  • 计算化学是一种计算化学.
  • 药品化学 药品化学 是一个
  • 机器学习在药物发现中的作用

背景情况:

  • 设计-制造-测试-分析 (DMTA) 周期对于临床前药物发现至关重要,但受到时间和成本的限制.
  • 模拟DMTA循环可以有效地探索影响其有效性的因素.

研究的目的:

  • 介绍SimDMTA,一个用于模拟DMTA循环的in silico框架.
  • 评估不同的采样策略,在DMTA循环中发现和推广模型.

主要方法:

  • 开发了一个模拟DMTA循环的in silico框架 (SimDMTA).
  • 利用机器学习模型预测对接分数,作为生物测试的代理.
  • 采用各种查询策略,包括基于不确定性的抽样,用于复合选择和代模型再训练.
  • 聚焦于从3,5-二甲基-4-二化醇支架中衍生出来的分子,准基4 (BRD4) BD1结合部位.

主要成果:

  • 基于不确定性的采样在发现命中中中显著超过了贪和混合方法.
  • 基于不确定性的抽样增强了预测模型的概括能力.
  • 到最后一次代时,排名前50名的化合物中有37个位于评估化学空间的前1%中.
  • 结合随机选择的策略改善了偏差校正,但在识别顶级分子方面效率较低.

结论:

  • 将分子多样性和不确定性纳入积极学习设计策略中,可以加快模型的改进,并改善命中识别.
  • 基于不确定性的采样是有效的临床前药物发现模拟的优越策略.
  • SimDMTA提供了一种可行的方法来探索超越传统实验限制的DMTA循环效率.